1. Home
  2. PNNT vs CVRX Comparison

PNNT vs CVRX Comparison

Compare PNNT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNNT
  • CVRX
  • Stock Information
  • Founded
  • PNNT 2007
  • CVRX 2000
  • Country
  • PNNT United States
  • CVRX United States
  • Employees
  • PNNT N/A
  • CVRX N/A
  • Industry
  • PNNT Finance: Consumer Services
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PNNT Finance
  • CVRX Health Care
  • Exchange
  • PNNT Nasdaq
  • CVRX Nasdaq
  • Market Cap
  • PNNT 462.3M
  • CVRX 419.8M
  • IPO Year
  • PNNT 2007
  • CVRX 2021
  • Fundamental
  • Price
  • PNNT $7.08
  • CVRX $12.53
  • Analyst Decision
  • PNNT Hold
  • CVRX Strong Buy
  • Analyst Count
  • PNNT 2
  • CVRX 7
  • Target Price
  • PNNT $6.00
  • CVRX $17.83
  • AVG Volume (30 Days)
  • PNNT 431.1K
  • CVRX 210.8K
  • Earning Date
  • PNNT 05-07-2025
  • CVRX 04-29-2025
  • Dividend Yield
  • PNNT 13.29%
  • CVRX N/A
  • EPS Growth
  • PNNT 11.30
  • CVRX N/A
  • EPS
  • PNNT 0.83
  • CVRX N/A
  • Revenue
  • PNNT $143,689,000.00
  • CVRX $51,292,000.00
  • Revenue This Year
  • PNNT N/A
  • CVRX $27.21
  • Revenue Next Year
  • PNNT N/A
  • CVRX $25.87
  • P/E Ratio
  • PNNT $8.45
  • CVRX N/A
  • Revenue Growth
  • PNNT N/A
  • CVRX 30.53
  • 52 Week Low
  • PNNT $6.43
  • CVRX $6.40
  • 52 Week High
  • PNNT $8.04
  • CVRX $19.24
  • Technical
  • Relative Strength Index (RSI)
  • PNNT 48.15
  • CVRX 48.53
  • Support Level
  • PNNT $6.97
  • CVRX $11.95
  • Resistance Level
  • PNNT $7.23
  • CVRX $12.94
  • Average True Range (ATR)
  • PNNT 0.08
  • CVRX 0.57
  • MACD
  • PNNT -0.00
  • CVRX 0.16
  • Stochastic Oscillator
  • PNNT 55.71
  • CVRX 66.39

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: